Dawn is a highly experienced pharmaceutical scientist, regulatory affairs professional, and strategic leader who joined Quantum as Senior Vice President and Co-Founder in May 2023. Dawn brings over 27 years of industry experience on both the Sponsor and CRO sides, with several years in international senior leadership including managing regulatory affairs, project management, drug development, and business development teams. She has extensive experience with regulatory due diligence assessments and was a significant contributor to the successful global drug development and approval in multiple therapeutic areas for a $400 million USD company. Dawn excels at building client relationships and solving complex problems by deploying proven strategies to overcome business hurdles, especially those with cultural, geographic, and international barriers.